文献速递临床试验与 GCP流行病学与生物统计

APPAC随机临床试验:无并发症急性阑尾炎抗生素治疗五年随访

Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

APPAC多中心随机临床试验纳入530例CT确诊的无并发症急性阑尾炎患者,随机接受阑尾切除术或抗生素治疗。五年随访显示,抗生素组5年阑尾炎复发累积发生率为39.1%,但总体并发症率显著低于手术组,支持抗生素单独作为手术替代方案。

要点

  • 抗生素组5年阑尾炎复发累积发生率为39.1%(95%CI 33.1%-45.3%)。
  • 5年总体并发症率抗生素组6.5%显著低于手术组24.4%(P<.001)。
  • 手术组病假时间比抗生素组多11天,住院时间无差异。

核心结论

  • 初始接受抗生素治疗的无并发症急性阑尾炎患者5年内阑尾炎复发累积发生率为39.1%。
  • 长期随访支持抗生素单独治疗作为无并发症急性阑尾炎手术替代方案的可行性。

研究设计与样本

  • APPAC多中心随机临床试验的五年观察性随访,比较阑尾切除术与抗生素治疗。
  • 纳入530例18至60岁CT确诊的无并发症急性阑尾炎患者,随机分为阑尾切除术组(n=273)和抗生素组(n=257)。
  • 抗生素方案为静脉厄他培南3天,继以口服左氧氟沙星和甲硝唑7天。

主要发现

  • 抗生素组中70例(27.3%,95%CI 22.0%-33.2%,70/256)在1年内接受阑尾切除术,另有30例(16.1%,95%CI 11.2%-22.2%,30/186)在1至5年间接受阑尾切除术。
  • 阑尾炎复发累积发生率2年为34.0%(95%CI 28.2%-40.1%),3年为35.2%(95%CI 29.3%-41.4%),4年为37.1%(95%CI 31.2%-43.3%),5年为39.1%(95%CI 33.1%-45.3%)。
  • 抗生素组85例后续因复发阑尾炎行阑尾切除术的患者中,76例为无并发症阑尾炎,2例为复杂阑尾炎,7例无阑尾炎。
  • 5年总体并发症率(手术部位感染、切口疝、腹痛和梗阻症状)手术组为24.4%(95%CI 19.2%-30.3%,60/246),抗生素组为6.5%(95%CI 3.8%-10.4%,16/246),P<.001,手术组高出17.9个百分点(95%CI 11.7-24.1)。
  • 两组住院时间无差异,但手术组病假时间多11天。

临床怎么用

  • 对于CT确诊的无并发症急性阑尾炎,抗生素治疗可作为手术的替代方案,但需告知患者5年内约39.1%的复发风险。
  • 抗生素治疗可显著降低总体并发症率并减少病假时间,但部分患者最终仍需阑尾切除术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Short-term results support antibiotics as an alternative to surgery for treating uncomplicated acute appendicitis, but long-term outcomes are not known. OBJECTIVE: To determine the late recurrence rate of appendicitis after antibiotic therapy for the treatment of uncomplicated acute appendicitis. DESIGN, SETTING, AND PARTICIPANTS: Five-year observational follow-up of patients in the Appendicitis Acuta (APPAC) multicenter randomized clinical trial comparing appendectomy with antibiotic therapy, in which 530 patients aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis were randomized to undergo an appendectomy (n = 273) or receive antibiotic therapy (n = 257). The initial trial was conducted from November 2009 to June 2012 in Finland; last follow-up was September 6, 2017. This current analysis focused on assessing the 5-year outcomes for the group of patients treated with antibiotics alone. INTERVENTIONS: Open appendectomy vs antibiotic therapy with intravenous ertapenem for 3 days followed by 7 days of oral levofloxacin and metronidazole. MAIN OUTCOMES AND MEASURES: In this analysis, prespecified secondary end points reported at 5-year follow-up included late (after 1 year) appendicitis recurrence after antibiotic treatment, complications, length of hospital stay, and sick leave. RESULTS: Of the 530 patients (201 women; 329 men) enrolled in the trial, 273 patients (median age, 35 years [IQR, 27-46]) were randomized to undergo appendectomy, and 257 (median age, 33 years, [IQR, 26-47]) were randomized to receive antibiotic therapy. In addition to 70 patients who initially received antibiotics but underwent appendectomy within the first year (27.3% [95% CI, 22.0%-33.2%]; 70/256), 30 additional antibiotic-treated patients (16.1% [95% CI, 11.2%-22.2%]; 30/186) underwent appendectomy between 1 and 5 years. The cumulative incidence of appendicitis recurrence was 34.0% (95% CI, 28.2%-40.1%; 87/256) at 2 years, 35.2% (95% CI, 29.3%-41.4%; 90/256) at 3 years, 37.1% (95% CI, 31.2%-43.3%; 95/256) at 4 years, and 39.1% (95% CI, 33.1%-45.3%; 100/256) at 5 years. Of the 85 patients in the antibiotic group who subsequently underwent appendectomy for recurrent appendicitis, 76 had uncomplicated appendicitis, 2 had complicated appendicitis, and 7 did not have appendicitis. At 5 years, the overall complication rate (surgical site infections, incisional hernias, abdominal pain, and obstructive symptoms) was 24.4% (95% CI, 19.2%-30.3%) (n = 60/246) in the appendectomy group and 6.5% (95% CI, 3.8%-10.4%) (n = 16/246) in antibiotic group (P < .001), which calculates to 17.9 percentage points (95% CI, 11.7-24.1) higher after surgery. There was no difference between groups for length of hospital stay, but there was a significant difference in sick leave (11 days more for the appendectomy group). CONCLUSIONS AND RELEVANCE: Among patients who were initially treated with antibiotics for uncomplicated acute appendicitis, the likelihood of late recurrence within 5 years was 39.1%. This long-term follow-up supports the feasibility of antibiotic treatment alone as an alternative to surgery for uncomplicated acute appendicitis. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01022567.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Salminen P, Tuominen R, Paajanen H, et al. Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial. JAMA. 2018. PMID: 30264120. doi:10.1001/jama.2018.13201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。